Zymeworks Inc
5.0 out of 5 stars.
Get weekly updates, new jobs, and reviews

About Zymeworks Inc

Zymeworks is a clinical-stage biopharmaceutical company dedicated to the development of next-generation multifunctional biotherapeutics. Zymeworks’ suite of therapeutic platforms and its fully integrated drug development engine enable precise engineering of highly differentiated product candidates. Zymeworks’ lead product candidate, zanidatamab (ZW25), – 

Zymeworks